MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin

Erika Cecchin,Gabriele Perrone,Stefania Nobili,J Polesel,E. De Mattia,Chiara Zanusso,P. Petreni,Sara Lonardi,Nicoletta Pella,Mario D'Andrea,D. Errante,Flavio Rizzolio,Teresita Mazzei,Ida Landini,Enrico Mini,Giuseppe Toffoli

MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin

2015

Erika Cecchin
Gabriele Perrone
Stefania Nobili
J Polesel
E. De Mattia
Chiara Zanusso
P. Petreni
Sara Lonardi
Nicoletta Pella
Mario D'Andrea
D. Errante
Flavio Rizzolio
Teresita Mazzei
Ida Landini
Enrico Mini
Giuseppe Toffoli

MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin

Keywords:

Pharmacology
Methylenetetrahydrofolate reductase
Colorectal cancer
Cancer research
Adjuvant
Oxaliplatin
Immunology
Biology
Chemotherapy
Internal medicine
Oncology
stage ii

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations